New Products

BRIDGEWATER, N.J. — Ajanta Pharma USA on Friday announced the launch of risperidone tablets (0.25-mg, 0.5-mg, 1-mg, 2-mg, 3-mg and 4-mg), the generic version of Risperdal. The drug is used to treat schizophrenia and bipolar disorder.

Sales of branded and generic risperidone totalled approximately $147 million for the 12 months ending March 2014, according to IMS Health.

SUWANEE, Ga. — Enaltus recently announced three new additions to its line of ScarAway scar removal products. 

First is ScarAway Scar Repair Gel, featuring patented Kelo-cote technology, a transparent, self-drying 100%-silicone gel designed to improve the appearance of scars and prevent abnormal and excessive scar formation. The transparent gel offers convenient application for custom scar prevention and treatment that can begin the moment a wound has healed or sutures are removed. ScarAway Scar Repair Gel retails for a suggested $29.99. 

MADISON, Wis. — Propeller Health, the FDA-cleared digital health solution for chronic respiratory disease, earlier this week announced that the Food and Drug Administration granted 510(k) clearance to market its latest generation of the Propeller platform, including a new sensor.

ENGLEWOOD CLIFFS, N.J. — Global beauty brand Dove announced the launch of Dove DermaSeries, a range of cleansers and creams that can be used to care for extremely dry skin. DermaSeries marks the brand's first premium skin care line.

Dove partnered with dermatologists for the line to provide critical insight into the science behind dry skin, including Dr. Ranella Hirsch, a fellow of the American Academy of Dermatology.

ROCHESTER, N.Y. — Wegmans Food Markets is making it easy for patients to monitor their blood pressure with a stop to the pharmacy at any store, the company announced Wednesday. That’s where customers can find a health station that lets them take their own vital statistics and track them over time, providing the kind of record doctors often ask patients to keep. The Lifeclinic 500 stations can measure blood pressure, pulse, weight and calculate body mass index.

DUBLIN — Actavis announced that it has launched a generic version of Boehringer Ingelheim's Catapres-TTS (clonidine transdermal system, USP, 0.1-mg/day, 0.2-mg/day, and 0.3-mg/day for one week), following the company's final approval on its abbreviated new drug application from the Food and Drug Administration.

Catapres-TTS is used for the treatment of hypertension. The drug had total U.S. sales of approximately $180 million for the 12 months ending Feb. 28, 2014, according to IMS Health.

ENGLEWOOD CLIFFS, N.J. — Breyers announced that it will begin offering 36 gluten-free varieties, which will feature a "gluten-free" claim, in line with the Food and Drug Administration's rule on gluten-free labeling.

EL SEGUNDO, Calif. — Medical providers’ efforts to reduce costs by taking a more holistic approach to healthcare will spur a doubling in the global market for home health technologies in the coming years, according to an IHS Technology report released Thursday titled “World Market for Home Health Technologies – 2014.”